甲氨蝶呤-话题@MedSci

#甲氨蝶呤#

12篇内容 | 3299人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2231304, encodeId=418f22313041f, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=462d12022e63' target=_blank style='color:#2F92EE;'>#甲酰四氢叶酸#</a> <a href='/topic/show?id=4b151202284c' target=_blank style='color:#2F92EE;'>#谷卡匹酶#</a>, objectTitle=【指南分享】2024 欧洲共识建议：甲氨蝶呤消除延迟的管理—支持措施，甲酰四氢叶酸解救和谷卡匹酶治疗, objectType=article, longId=847367, objectId=613884e36725, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401017/1729132934226_8538692.jpg, objectUrl=/article/show_article.do?id=613884e36725, replyNumber=0, likeNumber=17, createdTime=2024-10-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=613884e36725, moduleTitle=【指南分享】2024 欧洲共识建议：甲氨蝶呤消除延迟的管理—支持措施，甲酰四氢叶酸解救和谷卡匹酶治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=613884e36725)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224794, encodeId=ac5b2224e94cd, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=820e3228e1b' target=_blank style='color:#2F92EE;'>#利妥昔单抗#</a> <a href='/topic/show?id=6a1c60356fb' target=_blank style='color:#2F92EE;'>#替莫唑胺#</a> <a href='/topic/show?id=f7603e0370d' target=_blank style='color:#2F92EE;'>#原发性中枢神经系统淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=【STTT】信迪利单抗、大剂量甲氨蝶呤、替莫唑胺和利妥昔单抗治疗PCNSL的2期研究, objectType=article, longId=842351, objectId=9fbc8423516f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240722/1721615892206_92910.jpg, objectUrl=/article/show_article.do?id=9fbc8423516f, replyNumber=0, likeNumber=76, createdTime=2024-09-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9fbc8423516f, moduleTitle=【STTT】信迪利单抗、大剂量甲氨蝶呤、替莫唑胺和利妥昔单抗治疗PCNSL的2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fbc8423516f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223972, encodeId=42cf22239e2b9, content=<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a> <a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a>, objectTitle=优化RA治疗：甲氨蝶呤（预充式）诊疗管理新策略, objectType=article, longId=841771, objectId=3f05841e7104, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240904/1725414302049_5134304.png, objectUrl=/article/show_article.do?id=3f05841e7104, replyNumber=0, likeNumber=71, createdTime=2024-09-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3f05841e7104, moduleTitle=优化RA治疗：甲氨蝶呤（预充式）诊疗管理新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f05841e7104)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2219518, encodeId=2e93221951813, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=59088589e97' target=_blank style='color:#2F92EE;'>#膝骨关节炎#</a>, objectTitle=最新研究：老药新用，缓解关节疼痛、僵硬，6个月效果明显！, objectType=article, longId=838502, objectId=4a7583850212, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240723/1721700051889_8538692.jpg, objectUrl=/article/show_article.do?id=4a7583850212, replyNumber=0, likeNumber=72, createdTime=2024-08-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4a7583850212, moduleTitle=最新研究：老药新用，缓解关节疼痛、僵硬，6个月效果明显！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a7583850212)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214759, encodeId=09fa2214e59c4, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=053d2148601' target=_blank style='color:#2F92EE;'>#中医药#</a> <a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a> <a href='/topic/show?id=8d82e952353' target=_blank style='color:#2F92EE;'>#网络药理学#</a>, objectTitle=J Inflamm Res：络痹通片通过靶向多种炎症途径增强MTX抗类风湿关节炎活性, objectType=article, longId=834328, objectId=4799834328e1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240713/1720800968881_5610093.jpg, objectUrl=/article/show_article.do?id=4799834328e1, replyNumber=0, likeNumber=113, createdTime=2024-07-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4799834328e1, moduleTitle=J Inflamm Res：络痹通片通过靶向多种炎症途径增强MTX抗类风湿关节炎活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4799834328e1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212590, encodeId=c63a221259081, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=4e0c13860de' target=_blank style='color:#2F92EE;'>#PCNSL#</a> <a href='/topic/show?id=f7603e0370d' target=_blank style='color:#2F92EE;'>#原发性中枢神经系统淋巴瘤#</a>, objectTitle=【Neuro Oncol】559例原发性中枢神经系统淋巴瘤的结局和复发模式, objectType=article, longId=832396, objectId=ff928323964a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719536613804_5579292.png, objectUrl=/article/show_article.do?id=ff928323964a, replyNumber=0, likeNumber=123, createdTime=2024-07-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ff928323964a, moduleTitle=【Neuro Oncol】559例原发性中枢神经系统淋巴瘤的结局和复发模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff928323964a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205190, encodeId=6c0022051908e, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=373612342c7' target=_blank style='color:#2F92EE;'>#MTX#</a> <a href='/topic/show?id=33aa1088832d' target=_blank style='color:#2F92EE;'>#填充剂#</a>, objectTitle=确认过效果：低剂量口服甲氨蝶呤治疗皮肤填充剂迟发性炎症反应, objectType=article, longId=826260, objectId=bf04826260e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240517/1715927461816_5579292.jpg, objectUrl=/article/show_article.do?id=bf04826260e0, replyNumber=0, likeNumber=87, createdTime=2024-05-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=bf04826260e0, moduleTitle=确认过效果：低剂量口服甲氨蝶呤治疗皮肤填充剂迟发性炎症反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf04826260e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201740, encodeId=b1722201e40f2, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=a798e520582' target=_blank style='color:#2F92EE;'>#移植物抗宿主病#</a> <a href='/topic/show?id=00a18335de' target=_blank style='color:#2F92EE;'>#GVHD#</a> <a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, objectTitle=【BMC Med】微小剂量甲氨蝶呤联合甲泼尼龙用于急性GVHD初始治疗的3期研究, objectType=article, longId=824253, objectId=1d62824253e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=1d62824253e5, replyNumber=0, likeNumber=115, createdTime=2024-05-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1d62824253e5, moduleTitle=【BMC Med】微小剂量甲氨蝶呤联合甲泼尼龙用于急性GVHD初始治疗的3期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d62824253e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196313, encodeId=104b219631367, content=<a href='/topic/show?id=518761566e4' target=_blank style='color:#2F92EE;'>#来那度胺#</a> <a href='/topic/show?id=820e3228e1b' target=_blank style='color:#2F92EE;'>#利妥昔单抗#</a> <a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=f7603e0370d' target=_blank style='color:#2F92EE;'>#原发性中枢神经系统淋巴瘤#</a>, objectTitle=来那度胺、利妥昔单抗和甲氨蝶呤联合对新诊断的原发性中枢神经系统淋巴瘤有效, objectType=article, longId=813024, objectId=ddbe813024e9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=ddbe813024e9, replyNumber=0, likeNumber=108, createdTime=2024-03-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ddbe813024e9, moduleTitle=来那度胺、利妥昔单抗和甲氨蝶呤联合对新诊断的原发性中枢神经系统淋巴瘤有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddbe813024e9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2196009, encodeId=5b6a219600982, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a>, objectTitle=甲氨蝶呤（预充式）｜老药新衣，为克罗恩病患者长期用药助力！, objectType=article, longId=819455, objectId=aee0819455bf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240329/1711675358233_5134304.png, objectUrl=/article/show_article.do?id=aee0819455bf, replyNumber=0, likeNumber=108, createdTime=2024-03-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=aee0819455bf, moduleTitle=甲氨蝶呤（预充式）｜老药新衣，为克罗恩病患者长期用药助力！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aee0819455bf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2192923, encodeId=0f15219292370, content=<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a> <a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a>, objectTitle=始于循证，终于临床，抗风湿神药甲氨蝶呤皮下注射优化治疗, objectType=article, longId=816933, objectId=b28081693383, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240313/1710296990308_5134304.jpg, objectUrl=/article/show_article.do?id=b28081693383, replyNumber=0, likeNumber=139, createdTime=2024-03-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b28081693383, moduleTitle=始于循证，终于临床，抗风湿神药甲氨蝶呤皮下注射优化治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b28081693383)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184580, encodeId=99362184580c4, content=<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a> <a href='/topic/show?id=257ae692755' target=_blank style='color:#2F92EE;'>#系统性红斑狼疮#</a> <a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a>, objectTitle=甲氨蝶呤注射液（预充式）获批上市，再次掀起「注射药vs.口服药大战」，一文回顾甲氨蝶呤“上位史”！, objectType=article, longId=777819, objectId=b30ae77819d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230620/1687245570531_5134304.jpg, objectUrl=/article/show_article.do?id=b30ae77819d8, replyNumber=0, likeNumber=113, createdTime=2024-01-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b30ae77819d8, moduleTitle=甲氨蝶呤注射液（预充式）获批上市，再次掀起「注射药vs.口服药大战」，一文回顾甲氨蝶呤“上位史”！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b30ae77819d8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184289, encodeId=3ede2184289a2, content=<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a> <a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=e0d7546812c' target=_blank style='color:#2F92EE;'>#托珠单抗#</a> <a href='/topic/show?id=53db6942572' target=_blank style='color:#2F92EE;'>#生物类似药#</a> <a href='/topic/show?id=20891106008b' target=_blank style='color:#2F92EE;'>#曾小峰#</a>, objectTitle=Lancet Rheumatol：托珠单抗生物类似药 BAT1806/BIIB800 对甲氨蝶呤反应不足的中重度类风湿性关节炎患者安全有效, objectType=article, longId=811265, objectId=74178112650a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240123/ba0db996ff97459fa2ad1d9e029c3255.jpg, objectUrl=/article/show_article.do?id=74178112650a, replyNumber=0, likeNumber=98, createdTime=2024-01-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亚, moduleDTOList=[ModuleDTO(moduleId=74178112650a, moduleTitle=Lancet Rheumatol：托珠单抗生物类似药 BAT1806/BIIB800 对甲氨蝶呤反应不足的中重度类风湿性关节炎患者安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74178112650a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182702, encodeId=922b2182e0280, content=<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a> <a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a>, objectTitle=甲氨蝶呤是关键！掌握6大要点，为500万类风湿关节炎患者做好用药管理, objectType=article, longId=810126, objectId=1310810126ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240119/1705667406150_5134304.jpg, objectUrl=/article/show_article.do?id=1310810126ad, replyNumber=0, likeNumber=117, createdTime=2024-01-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1310810126ad, moduleTitle=甲氨蝶呤是关键！掌握6大要点，为500万类风湿关节炎患者做好用药管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1310810126ad)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182507, encodeId=9eca218250e12, content=<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a> <a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=e0d7546812c' target=_blank style='color:#2F92EE;'>#托珠单抗#</a>, objectTitle=长期受类风湿关节炎折磨？《柳叶刀》子刊：新疗法助力患者病情缓解，惠及更多人群, objectType=article, longId=809933, objectId=edcc80993314, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-in-his-practice-with-a-digital-tablet-UWZKVBN.jpg, objectUrl=/article/show_article.do?id=edcc80993314, replyNumber=0, likeNumber=125, createdTime=2024-01-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=edcc80993314, moduleTitle=长期受类风湿关节炎折磨？《柳叶刀》子刊：新疗法助力患者病情缓解，惠及更多人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edcc80993314)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181702, encodeId=0a0a2181e0295, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a>, objectTitle=JAMA Netw Open：常规抗风湿药物与糖皮质激素单药治疗类风湿性关节炎的有效性比较, objectType=article, longId=809455, objectId=4d7b809455f5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240114/1705244701644_5485250.jpg, objectUrl=/article/show_article.do?id=4d7b809455f5, replyNumber=0, likeNumber=102, createdTime=2024-01-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4d7b809455f5, moduleTitle=JAMA Netw Open：常规抗风湿药物与糖皮质激素单药治疗类风湿性关节炎的有效性比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d7b809455f5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181224, encodeId=18a02181224a5, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=76fe49e195a' target=_blank style='color:#2F92EE;'>#异位妊娠#</a>, objectTitle=我们能预测甲氨蝶呤治疗异位妊娠的时限吗？, objectType=article, longId=809268, objectId=4c8480926810, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/patient-meeting-a-doctor-PAYSRMZ.jpg, objectUrl=/article/show_article.do?id=4c8480926810, replyNumber=0, likeNumber=98, createdTime=2024-01-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=4c8480926810, moduleTitle=我们能预测甲氨蝶呤治疗异位妊娠的时限吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c8480926810)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2179694, encodeId=f39621e969468, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a> <a href='/topic/show?id=5512931805' target=_blank style='color:#2F92EE;'>#ibrutinib#</a> <a href='/topic/show?id=3d5d22290a4' target=_blank style='color:#2F92EE;'>#中枢神经系统淋巴瘤#</a>, objectTitle=老年原发中枢神经系统淋巴瘤患者一线大剂量甲氨蝶呤化疗后Ibrutinib维持的2期研究, objectType=article, longId=807808, objectId=932480e80831, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=932480e80831, replyNumber=0, likeNumber=92, createdTime=2024-01-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=932480e80831, moduleTitle=老年原发中枢神经系统淋巴瘤患者一线大剂量甲氨蝶呤化疗后Ibrutinib维持的2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=932480e80831)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2164336, encodeId=4f1e2164336a8, content=<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a>在<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a>患者中的应用, objectTitle=2023 JCR指南：甲氨蝶呤在类风湿关节炎患者中的应用, objectType=guider, longId=26719, objectId=2a96c1c003a080d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=2a96c1c003a080d4, replyNumber=0, likeNumber=130, createdTime=2023-10-23, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2a96c1c003a080d4, moduleTitle=2023 JCR指南：甲氨蝶呤在类风湿关节炎患者中的应用, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=2a96c1c003a080d4)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2163761, encodeId=4b242163e61aa, content=食用<a href='/topic/show?id=674769813be' target=_blank style='color:#2F92EE;'>#甲氨蝶呤#</a>对生育的影响, objectTitle=男性使用甲氨蝶呤对生育有不良影响吗？, objectType=article, longId=796728, objectId=56a3e9672838, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017217327_4754896.png, objectUrl=/article/show_article.do?id=56a3e9672838, replyNumber=0, likeNumber=108, createdTime=2023-10-19, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=56a3e9672838, moduleTitle=男性使用甲氨蝶呤对生育有不良影响吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56a3e9672838)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] 梅斯话题小助手

甲氨蝶呤

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #甲酰四氢叶酸# #谷卡匹酶#

【指南分享】2024 欧洲共识建议：甲氨蝶呤消除延迟的管理—支持措施，甲酰四氢叶酸解救和谷卡匹酶治疗

2024-10-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #利妥昔单抗# #替莫唑胺# #原发性中枢神经系统淋巴瘤# #信迪利单抗#

【STTT】信迪利单抗、大剂量甲氨蝶呤、替莫唑胺和利妥昔单抗治疗PCNSL的2期研究

2024-09-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#类风湿关节炎# #甲氨蝶呤#

优化RA治疗：甲氨蝶呤（预充式）诊疗管理新策略

2024-09-04发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #膝骨关节炎#

最新研究：老药新用，缓解关节疼痛、僵硬，6个月效果明显！

2024-08-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #中医药# #类风湿性关节炎# #网络药理学#

J Inflamm Res：络痹通片通过靶向多种炎症途径增强MTX抗类风湿关节炎活性

2024-07-13发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #PCNSL# #原发性中枢神经系统淋巴瘤#

【Neuro Oncol】559例原发性中枢神经系统淋巴瘤的结局和复发模式

2024-07-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #MTX# #填充剂#

确认过效果：低剂量口服甲氨蝶呤治疗皮肤填充剂迟发性炎症反应

2024-05-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤# #移植物抗宿主病# #GVHD# #甲泼尼龙#

【BMC Med】微小剂量甲氨蝶呤联合甲泼尼龙用于急性GVHD初始治疗的3期研究

2024-05-04发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#来那度胺# #利妥昔单抗# #甲氨蝶呤# #原发性中枢神经系统淋巴瘤#

来那度胺、利妥昔单抗和甲氨蝶呤联合对新诊断的原发性中枢神经系统淋巴瘤有效

2024-03-31发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#甲氨蝶呤#

甲氨蝶呤（预充式）｜老药新衣，为克罗恩病患者长期用药助力！

2024-03-29发表于上海

梅斯管理员 (审核中...)